Topical imiquimod treatment of a cutaneous melanoma metastasis [1]

Journal of the American Academy of Dermatology

Volumn 43, Issue 3, 2000, Pages 555-556

  Steinmann, A ^a   Funk, J O ^a   Schuler, G ^a   Von den Driesch, P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ANTINEOPLASTIC ACTIVITY; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; LETTER; MELANOMA; PRIORITY JOURNAL; SKIN METASTASIS;

EID: 0033859336     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.10795     Document Type: Letter

References (5)

1. Modulation of TH1 and TH2 cytokine production with the immune response modifiers R-848 and imiquimod
2. Self-administered topical 5% imiquimod cream for external anogenital warts
3. Tolerance, danger, and the extended family
4. Dendritic cells as adjuvants for immune-mediated resistance to tumors
5. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs